P279 A patient survey evaluating COVID-19-induced changes in follow-up of patients with EBC: opportunities for enhanced evidence-based practice?

por Beltran-Bless, A.-A., Larocque, G., Brackstone, M., Arnaout, A., Caudrelier, J.-M., Boone, D., Fallah, P., Ng, T., Cross, P., Alqahtani, N., Hilton, J., Vandermeer, L., Pond, G., Clemons, M.
Publicado 2023

The JAK inhibitor ruxolitinib reduces inflammation in an ILC3-independent model of innate immune colitis

por Overstreet, A.M., LaTorre, D.L., Abernathy-Close, L., Murphy, S.F., Rhee, L., Boger, A.M., Adlaka, K.R., Iverson, A.M., Bakke, D.S., Weber, C.R., Boone, D.L.
Publicado 2018